NCT06517927 Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10
| NCT ID | NCT06517927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Condition | Chemotherapy Effect |
| Study Type | INTERVENTIONAL |
| Enrollment | 142 participants |
| Start Date | 2024-05-03 |
| Primary Completion | 2026-05-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 142 participants in total. It began in 2024-05-03 with a primary completion date of 2026-05-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To date, there are no methods for assessing the risk of oral developmental defects that could predict long-term adverse effects in childhood cancer survivors. Having such a method at our disposal would enable us to better assess the risk to develop those defects and will help us provide new prevention and treatment strategies to ensure a healthy oral development. The aims of this study are : * Assess the caries risk in childhood cancer survivors compared with a control group. * Assess the dental development defects risk in childhood cancer survivors compared with a control group.
Eligibility Criteria
Inclusion Criteria: * age below 10 at cancer diagnosis (for the CCS group). * Chemotherapy must have been used to treat the patient (For the CCS group). * The patient is 12 years old or older at the time of the follow-up appointment of the present study Exclusion Criteria: * A patient who was diagnosed and treated after 10 years old. * Patient below 12 years old at time of study recruitment * Patients with syndrome or diseases that involve teeth impairment\* * Pregnant patient * Refusal or inaptitude to undergo dental and radiographic examination
Contact & Investigator
Maëlle De Ville de Goyet
PRINCIPAL INVESTIGATOR
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Frequently Asked Questions
Who can join the NCT06517927 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 36 Years, studying Chemotherapy Effect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06517927 currently recruiting?
Yes, NCT06517927 is actively recruiting participants. Contact the research team at armand.irakoze@uclouvain.be for enrollment information.
Where is the NCT06517927 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT06517927 clinical trial?
NCT06517927 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The principal investigator is Maëlle De Ville de Goyet at Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The trial plans to enroll 142 participants.